Product Information

CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by NorthStar Rx LLC, priced at $0.2170 per ML under NDC 16714039702. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 250 MG/5 ML SUSP

Cefprozil
$0.2170per ML

Strength

250 mg/5mL

Manufacturer

NorthStar Rx LLC

NDC

16714039702

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065381

FDA Approved

1/30/2007

TE Code

AB

On Market Since

1/30/2007

Price Statistics

The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 61.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2170 per ML
All-time high$0.5641 (Jun 11, 2014)
All-time low$0.1433 (Aug 21, 2024)
52-week high$0.2170
52-week low$0.1655
Median price$0.2702
Average price$0.3278
Largest weekly change+58.3% (Feb 23, 2022)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+4.6%

1M

+4.6%

3M

+9.4%

6M

+2.5%

1Y

+31.1%

3Y

-5.2%

5Y

-39.0%

All

-61.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by NorthStar Rx LLC, is $0.2170 per ML (NDC 16714039702), effective Aug 19, 2026.

How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 61.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1433 (Aug 21, 2024) to a high of $0.5641 (Jun 11, 2014), with a median of $0.2702 per ML.

Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 250 MG/5 ML SUSP, is $0.1470 per ML — about 32% below CEFPROZIL 250 MG/5 ML SUSP.

Who manufactures CEFPROZIL 250 MG/5 ML SUSP?

CEFPROZIL 250 MG/5 ML SUSP (NDC 16714039702) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.